Skip to content
English

CKD Management & Progression Slowing

We slow the loss of kidney function with blood pressure care and SGLT2 inhibitor medicine. We also treat the anemia, bone disease, and acid buildup that come with it, at Remix Medical in Houston, TX.

Chronic kidney disease is not one thing that happens to you. It is a rate — how fast function is being lost. Almost everything we do is aimed at slowing that rate.

What actually changes the trajectory

Most of what protects a kidney is unglamorous and enormously effective.

Blood pressure. The single largest modifiable factor. Target is generally under 120 systolic when tolerated, and getting there often takes three or four medications.

SGLT2 inhibitors. The most significant advance in kidney medicine in thirty years. Dapagliflozin and empagliflozin slow progression substantially, in patients with and without diabetes. If you have CKD with protein in the urine, you should be on one unless there is a reason you cannot be.

ACE inhibitors or ARBs. They reduce proteinuria and protect the kidney beyond their effect on blood pressure. A modest rise in creatinine after starting one is expected and is not a reason to stop.

Finerenone. For diabetic kidney disease, added on top of the above.

Glucose control, if you are diabetic.

Stopping the drugs that are hurting you. NSAIDs, certain antibiotics, contrast studies ordered without thought. A large fraction of preventable kidney injury comes from medications.

What we manage alongside it

CKD does not fail alone. Each of these is treated as its own problem, on its own schedule.

  • Anemia — the kidney stops making erythropoietin
  • Bone and mineral disease — phosphorus rises, calcium falls, parathyroid hormone climbs
  • Metabolic acidosis — corrected with bicarbonate, which itself slows progression
  • Potassium — which often constrains the very medications that protect the kidney
  • Cardiovascular risk — far more CKD patients die of heart disease than reach dialysis
TherapyWhat it does for your kidneys
SGLT2 inhibitorsSlow the decline toward kidney failure and protect the heart
FinerenoneLowers kidney and cardiovascular risk in diabetic kidney disease
ACE inhibitors / ARBsEase pressure inside the kidney's filters — often underdosed
Blood pressure & diabetes controlThe foundation that everything else builds on

Chronic kidney disease treatment by stage

The same core treatment applies at every stage. What changes is what gets added.

  • Stages 1 and 2: find the cause, control blood pressure and blood sugar, and start kidney-protective drugs if there is protein in the urine. Check yearly.
  • Stage 3: everything above, plus screening for anemia, acid buildup, and bone and mineral changes. Most patients should be seeing a nephrologist by now.
  • Stage 4: everything above, checked more often, and the conversation about dialysis, transplant, and conservative care begins.
  • Stage 5: kidney failure. Treatment is a transplant, dialysis, or conservative care, chosen ahead of time.

Advanced planning

When your eGFR falls below 30, we start talking about what comes next — not because it is imminent, but because the patients who do well are the ones who had time to choose.

Below 20, you can be evaluated for transplant and listed before dialysis ever begins. If you will need dialysis, a fistula takes three to six months to mature. Rushing these decisions is how people end up with a catheter in their neck in an emergency room.

Kidney failure treatment options

When the kidneys can no longer keep up, there are three paths. All three are worth understanding before you need one.

  • Kidney transplant. The best outcomes for most patients who qualify. A transplant done before dialysis starts (preemptive) does better than one done after. A living donor shortens the wait considerably.
  • Dialysis. Hemodialysis is done in a center about three times a week, or at home. Peritoneal dialysis is done at home every day, often overnight while you sleep.
  • Conservative kidney care. For some older or very ill patients, dialysis adds treatment burden without adding much time. Conservative care manages symptoms, fluid, and potassium without dialysis. It is a legitimate choice, made with the patient and family.

What we track

At each visit: eGFR, urine albumin-to-creatinine ratio, potassium, bicarbonate, hemoglobin, phosphorus, calcium, and parathyroid hormone. The interval depends on your stage and how fast you are moving.

The slope of your eGFR over time tells us more than any single value. A patient at 35 who has been stable for six years and a patient at 35 who was at 55 last year are in entirely different situations.

How it's performed

Management centers on reducing the rate of eGFR decline. Blood pressure is titrated to target, typically below 120 systolic when tolerated. SGLT2 inhibitor therapy is initiated in patients with albuminuria regardless of diabetes status. Renin-angiotensin system blockade with an ACE inhibitor or ARB is maximized to reduce proteinuria. Finerenone is added in diabetic kidney disease. Nephrotoxic agents are identified and discontinued. Complications are treated in parallel: anemia, mineral and bone disorder, metabolic acidosis, hyperkalemia, and cardiovascular risk. Laboratory surveillance at each visit tracks eGFR, albumin-to-creatinine ratio, potassium, bicarbonate, hemoglobin, phosphorus, calcium, and parathyroid hormone. Below an eGFR of 30, planning for kidney replacement therapy begins; below 20, preemptive transplant evaluation is initiated.

How to prepare

Bring every medication you take, including over-the-counter drugs, supplements, and herbal products, to each visit. Many are nephrotoxic. If you monitor your blood pressure at home, bring the readings. Laboratory work is typically drawn before the visit so results can be reviewed together.

Outcome

A measurable reduction in the rate of eGFR decline. SGLT2 inhibitor therapy and renin-angiotensin blockade together substantially delay progression to kidney failure. Parallel management of anemia, mineral and bone disorder, and acidosis reduces morbidity, while early planning for transplant or dialysis produces markedly better outcomes than urgent, unplanned initiation.

Frequently asked

CKD Management & Progression Slowing questions, answered

What medications protect the kidneys?

SGLT2 inhibitors, ACE inhibitors or ARBs, and finerenone are among the therapies that slow progression. They're additive, so being on the full appropriate set helps most.

Can chronic kidney disease be slowed down?

Yes, and often significantly. Controlling blood pressure and blood sugar, plus modern kidney-protective medications, can meaningfully slow the decline.

How often should CKD be monitored?

Typically with regular blood and urine tests, more often as the disease advances. Tracking the trend, not just one value, is what guides treatment.

What can I do to protect my kidneys?

Keep your blood pressure and diabetes controlled, take your kidney-protective medications, avoid regular NSAIDs, stay active, and don't smoke. These steps add up.

Am I on all the right medications for my kidneys?

Many people are missing at least one kidney-protective therapy. It's worth reviewing your list with a nephrologist to make sure the plan is complete.

What medications should I avoid with chronic kidney disease?

NSAIDs including ibuprofen and naproxen. Certain antibiotics. Contrast dye when the study is not necessary. Many over-the-counter and herbal products. Bring everything you take, including supplements, to every visit.

Why do I need so many blood tests for my kidneys?

The slope of your eGFR over time tells us more than any single value. A patient stable at 35 for six years and a patient who fell from 55 to 35 in one year face entirely different situations and need entirely different plans.

Sources

References

  1. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int 2024;105(4S):S117–S314 — https://kdigo.org/guidelines/ckd-evaluation-and-management/
  2. KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease — https://kdigo.org/guidelines/blood-pressure-in-ckd/
  3. National Institute of Diabetes and Digestive and Kidney Diseases: Chronic Kidney Disease — https://www.niddk.nih.gov/health-information/kidney-disease/chronic-kidney-disease-ckd
  4. CDC: Chronic Kidney Disease in the United States, 2026 — https://www.cdc.gov/kidney-disease/media/pdfs/CKD-Factsheet-H.pdf
  5. CDC Kidney Disease Surveillance System — https://wwwn.cdc.gov/kdss/
SpecialtyNephrology & HypertensionTypeTherapyCPT code99213, 99214, 99215 (established patient E/M, moderate to high complexity); G0556, G0557, G0558 (Advanced Primary Care Management); 99490, 99439 (chronic care management); 99487, 99489 (complex chronic care management)

Also called Chronic Kidney Disease Management, CKD Care, Kidney Disease Progression Slowing, Renal Protection, Nephroprotection, CKD Treatment

This page is for general education and is not a substitute for medical advice. Whether a given procedure is appropriate depends on your individual evaluation. Contact a Remix Medical clinician to discuss your care.

Updated October 4, 2026. Medically reviewed by Uday Khosla, MD.

Ready to see a specialist?